FMR LLC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 92 filers reported holding UTAH MED PRODS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$33,525,466
-5.9%
389,831
+2.0%
0.00%0.0%
Q2 2023$35,611,068
-50.8%
382,093
-50.0%
0.00%0.0%
Q1 2023$72,415,274
+88.6%
764,116
+100.0%
0.00%
-25.0%
Q4 2022$38,405,778
+18.0%
382,033
+0.2%
0.00%
+33.3%
Q3 2022$32,541,000
-0.8%
381,436
-0.1%
0.00%0.0%
Q2 2022$32,787,000
-4.4%
381,681
-0.0%
0.00%0.0%
Q1 2022$34,301,000
-26.7%
381,712
-18.4%
0.00%0.0%
Q4 2021$46,773,000
+1.4%
467,723
-5.9%
0.00%
-25.0%
Q3 2021$46,129,000
+1.2%
496,863
-7.3%
0.00%0.0%
Q2 2021$45,589,000
-3.6%
536,087
-1.8%
0.00%0.0%
Q1 2021$47,282,000
+2.9%
545,975
+0.2%
0.00%0.0%
Q4 2020$45,941,000
+5.3%
544,973
-0.3%
0.00%0.0%
Q3 2020$43,646,000
-9.9%
546,471
+0.0%
0.00%
-20.0%
Q2 2020$48,419,000
+18.7%
546,364
+26.0%
0.01%
-16.7%
Q1 2020$40,776,000
-13.3%
433,556
-0.5%
0.01%
+20.0%
Q4 2019$47,033,000
+9.0%
435,898
-3.2%
0.01%0.0%
Q3 2019$43,157,000
-11.7%
450,298
-11.8%
0.01%
-16.7%
Q2 2019$48,880,000
+13.4%
510,763
+4.6%
0.01%
+20.0%
Q1 2019$43,089,000
+8.7%
488,255
+2.4%
0.01%0.0%
Q4 2018$39,630,000
-12.1%
477,007
-0.4%
0.01%0.0%
Q3 2018$45,108,000
-21.1%
478,856
-7.8%
0.01%
-28.6%
Q2 2018$57,183,000
+4.9%
519,139
-5.9%
0.01%
+16.7%
Q1 2018$54,519,000
+28.5%
551,528
+5.8%
0.01%
+20.0%
Q4 2017$42,416,000
+13.7%
521,089
+2.7%
0.01%0.0%
Q3 2017$37,311,000
+4.8%
507,287
+3.1%
0.01%
+25.0%
Q2 2017$35,619,000
+20.1%
491,977
+3.3%
0.00%0.0%
Q1 2017$29,661,000
-13.9%
476,105
+0.5%
0.00%
-20.0%
Q4 2016$34,463,000
+22.2%
473,721
+0.5%
0.01%
+25.0%
Q3 2016$28,191,000
-5.0%
471,420
+0.1%
0.00%0.0%
Q2 2016$29,666,000
+3.1%
470,889
+2.3%
0.00%0.0%
Q1 2016$28,775,000
+7.7%
460,100
+0.8%
0.00%0.0%
Q4 2015$26,723,000
+10.5%
456,485
+1.7%
0.00%
+33.3%
Q3 2015$24,185,000
-6.4%
448,956
+3.6%
0.00%0.0%
Q2 2015$25,834,000
+1.5%
433,236
+1.9%
0.00%0.0%
Q1 2015$25,441,000
-0.3%
425,0000.0%0.00%0.0%
Q4 2014$25,521,000
+23.2%
425,0000.0%0.00%0.0%
Q3 2014$20,723,000
-5.2%
425,0000.0%0.00%0.0%
Q2 2014$21,862,000
-11.1%
425,0000.0%0.00%0.0%
Q1 2014$24,578,000
+1.2%
425,0000.0%0.00%0.0%
Q4 2013$24,293,000
-3.8%
425,0000.0%0.00%
-25.0%
Q3 2013$25,262,000
+6.1%
425,000
-3.1%
0.00%0.0%
Q2 2013$23,806,000438,4180.00%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders